Equities research analysts predict that Validus Holdings, Ltd. (NYSE:VR) will announce earnings of $0.84 per share for the current fiscal quarter, Zacks Investment Research reports. Zero analysts have provided estimates for Validus’ earnings. Validus reported earnings per share of $0.95 in the same quarter last year, which suggests a negative year-over-year growth rate of 11.6%. The business is expected to announce its next quarterly earnings report on Wednesday, April 25th.
On average, analysts expect that Validus will report full year earnings of $4.13 per share for the current year, with EPS estimates ranging from $3.75 to $4.55. For the next financial year, analysts anticipate that the firm will post earnings of $4.55 per share, with EPS estimates ranging from $4.10 to $5.00. Zacks’ earnings per share averages are a mean average based on a survey of sell-side research firms that that provide coverage for Validus.
Validus (NYSE:VR) last posted its quarterly earnings data on Thursday, February 1st. The insurance provider reported $0.05 EPS for the quarter, missing analysts’ consensus estimates of $1.05 by ($1.00). Validus had a negative net margin of 4.60% and a negative return on equity of 0.99%. The firm had revenue of $346.88 million for the quarter, compared to analysts’ expectations of $352.00 million. During the same period in the prior year, the company posted $0.80 earnings per share. Validus’s quarterly revenue was up 16.1% compared to the same quarter last year.
A number of analysts have recently issued reports on VR shares. Zacks Investment Research reissued a “strong sell” rating on shares of Validus in a research report on Saturday, January 6th. Keefe, Bruyette & Woods lowered shares of Validus from an “outperform” rating to a “market perform” rating in a research report on Monday, January 22nd. Buckingham Research lowered shares of Validus from a “buy” rating to a “neutral” rating in a research report on Tuesday, February 13th. JMP Securities lowered shares of Validus from an “outperform” rating to a “market perform” rating in a research report on Tuesday, January 30th. Finally, Barclays reaffirmed a “hold” rating and set a $50.00 price objective on shares of Validus in a research report on Tuesday, January 9th. Two analysts have rated the stock with a sell rating, seven have assigned a hold rating and one has given a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus price target of $52.80.
In other Validus news, President Kean Driscoll sold 6,875 shares of the stock in a transaction that occurred on Friday, December 15th. The stock was sold at an average price of $46.16, for a total transaction of $317,350.00. Following the transaction, the president now owns 110,858 shares in the company, valued at $5,117,205.28. The sale was disclosed in a filing with the SEC, which is available at the SEC website. In the last quarter, insiders have sold 20,625 shares of company stock worth $1,102,544. Corporate insiders own 2.33% of the company’s stock.
Several institutional investors have recently made changes to their positions in VR. Boston Partners grew its stake in shares of Validus by 1,009.9% in the fourth quarter. Boston Partners now owns 4,279,398 shares of the insurance provider’s stock worth $200,789,000 after acquiring an additional 3,893,816 shares during the last quarter. Barrow Hanley Mewhinney & Strauss LLC acquired a new stake in shares of Validus in the third quarter worth $78,510,000. Victory Capital Management Inc. grew its stake in shares of Validus by 73.0% in the fourth quarter. Victory Capital Management Inc. now owns 1,985,484 shares of the insurance provider’s stock worth $93,159,000 after acquiring an additional 837,887 shares during the last quarter. Pzena Investment Management LLC grew its stake in shares of Validus by 87.2% in the fourth quarter. Pzena Investment Management LLC now owns 1,290,251 shares of the insurance provider’s stock worth $60,539,000 after acquiring an additional 601,187 shares during the last quarter. Finally, State Treasurer State of Michigan boosted its stake in Validus by 11.4% during the third quarter. State Treasurer State of Michigan now owns 3,798,643 shares of the insurance provider’s stock worth $186,931,000 after buying an additional 390,000 shares in the last quarter. Institutional investors and hedge funds own 95.01% of the company’s stock.
Validus (NYSE VR) traded down $0.06 during mid-day trading on Friday, reaching $67.54. 106,881 shares of the company’s stock were exchanged, compared to its average volume of 2,766,506. The company has a quick ratio of 0.95, a current ratio of 0.95 and a debt-to-equity ratio of 0.52. The stock has a market capitalization of $5,530.81, a price-to-earnings ratio of -78.60, a PEG ratio of 1.82 and a beta of 1.05. Validus has a 52 week low of $41.15 and a 52 week high of $67.73.
The business also recently declared a quarterly dividend, which will be paid on Thursday, March 29th. Shareholders of record on Thursday, March 15th will be issued a dividend of $0.38 per share. The ex-dividend date is Wednesday, March 14th. This represents a $1.52 annualized dividend and a yield of 2.25%. Validus’s dividend payout ratio (DPR) is presently -176.74%.
WARNING: “Validus Holdings, Ltd. (VR) Expected to Post Earnings of $0.84 Per Share” was reported by The Lincolnian Online and is the property of of The Lincolnian Online. If you are accessing this piece on another website, it was illegally copied and republished in violation of U.S. and international trademark & copyright law. The legal version of this piece can be read at https://www.thelincolnianonline.com/2018/02/20/validus-holdings-ltd-vr-expected-to-post-earnings-of-0-84-per-share.html.
Validus Holdings, Ltd. is a holding company. The Company operates through four segments: Validus Re, Talbot, Western World and AlphaCat. Validus Re is a Bermuda-based reinsurance segment focused treaty reinsurance. Validus Re concentrates on first-party property and other reinsurance risks. Talbot is a specialty insurance segment operating within the Lloyd’s insurance market through Syndicate 1183.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Validus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Validus and related companies with MarketBeat.com's FREE daily email newsletter.